title: [Platelet aggregation inhibitor in general practice. Every 3rd infarct prevented--reinfarction rate cut in half].
abstract: Depending on their mode of action, pharmaceuticals with an antithrombocytic effect are divided into five groups. In the doctor's office, acetylsalicylic acid (ASA) and the thienopyridines, such a ticlopidine and clopidogrel predominate. Acetylsalicylic acid should be considered for primary prevention in patients over 50 with a marked cardiovascular risk profile. In the secondary prophylaxis of myocardial infarction, life-long ASA treatment continues to be the treatment of choice. As an alternative, however, clopidogrel may be applied. A combination of acetylsalicylic acid and clopidogrel is recommended for patients who have been implanted with a stent. In patients with acute coronary syndrome, this regimen is superior to monotherapy with acetylsalicylic acid. In comparison with ticlopidine, clopidogrel has a more rapid onset of action, and has fewer side effects. In patients with an acute coronary syndrome and an elevated risk glycoprotein IIb/IIIa antagonists have proved highly effective.
authors.affiliation: I. Medizinische Klinik, Klinikum Augsburg. mfliri@yahoo.de
authors.forename: M
authors.initials: M
authors.lastname: Fliri
mesh_terms: D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D012008:Recurrence; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin